The Novel KSP Inhibitor ARRY-520 Is Active Both with and without Low-Dose Dexamethasone in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide: Results From a Phase 2 Study
| Autor: | Shah, Jatin J., Zonder, Jeffrey A., Cohen, Adam *, Bensinger, William *, Kaufman, Jonathan L., Orlowski, Robert Z., Harvey, R. Donald, Abidi, Muneer H., Thomas, Sheeba K., Walker, Duncan *, Hilder, Brandi *, Ptaszynski, Ann Marie *, Lonial, Sagar |
|---|---|
| Zdroj: | In Blood 16 November 2012 120(21):449-449 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|